Morning urinary assessment of nocturnal melatonin secretion in older women

Journal of Pineal Research

Volumn 28, Issue 1, 2000, Pages 41-47

  Cook, Mary R ^a   Graham, Charles ^a   Kavet, Robert ^b   Stevens, Richard G ^c   Davis, Scott ^d   Kheifets, Leeka ^b  

^a MIDWEST RESEARCH INSTITUTE   (United States)

^b ELECTRIC POWER RESEARCH INSTITUTE   (United States)

^c PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

6 OHMS; 6 Sulfatoxymelatonin; Age; Breast cancer; Melatonin

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; MELATONIN;

ADULT; AGED; AGING; ARTICLE; BREAST CANCER; CANCER RISK; CIRCADIAN RHYTHM; CLINICAL ARTICLE; ENZYME METABOLISM; FEMALE; HORMONE BLOOD LEVEL; HORMONE URINE LEVEL; HUMAN; UNITED STATES;

ADULT; AGED; BREAST NEOPLASMS; CIRCADIAN RHYTHM; FEMALE; HUMANS; MELATONIN; MIDDLE AGED; PINEAL GLAND; RADIOIMMUNOASSAY; RISK FACTORS;

EID: 0033966652     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-079X.2000.280106.x     Document Type: Article

References (17)

1. Arendt, J. (1995) Melatonin and the Mammalian Pineal Gland. Chapman and Hall, London, 331 p.
2. Bartsch, C., H. Bartsch, U. Fuchs (1989) Stage-dependent depression of melatonin in patients with primary breast cancer. Cancer 64:426-433.
3. Blask, D.E. (1993) Melatonin in oncology. In: Melatonin: Biosynthesis, Physiological Effects, and Clinical Applications, H.S. Yu, R. Reiter, eds. CRC Press, Boca Raton, FL, pp. 447-475.
4. Bojkowski, C.J., J. Arendt, M.C. Shih, S.P. Markey (1987) Melatonin secretion in humans assessed by measuring its metabolite, 6-sulfatoxymelatonin. Clin. Chem. 33:1343-1348.
5. Bojkowski, C.J., J. Arendt (1990) Factors influencing urinary 6-sulphatoxymelatonin, a major melatonin metabolite, in normal human subjects. J. Clin. Endocrinol. 33:435 444.
6. Brainard, G.C., R. Kavet, L.I. Kheifets (1999) The relationship between electromagnetic fields and light exposures to melatonin and breast cancer risk: A review of the relevant literature. J. Pineal Res. 26:65-100.
7. Brzezinski, A. (1997) Melatonin in humans. N. E. J. Med. 336:186-195.
8. Cohen, M., M. Lippmann, B. Chabner (1978) Role of the pineal gland in the aetiology and treatment of breast cancer. Lancet 2:814-816.
9. Graham, C., M.R. Cook, R. Kavet, A. Sastre, D.K. Smith (1998) Prediction of nocturnal plasma melatonin from morning urinary measures. J. Pineal Res. 24:230-238.
10. Kaune, W.T., S. Davis, R.G. Stevens (1997) Relation Between Residential Magnetic Fields, Light-At-Night, and Nocturnal Urine Melatonin Levels in Women. EPRI Report #TR-107242-VI, Palo Alto, CA.
11. Markey, S.P., S. Higa, M. Shih, D.M. Danforth, L. Tamarkin (1985) The correlation between human plasma melatonin levels and urinary 6-hydroxymelatonin excretion. Clin. Chim. Acta 150:221-225.
12. Nowak, R., I.C. McMillen, J. Redman, R.V. Short (1987) The correlation between serum and salivary melatonin concentrations and urinary 6-hydroxymelatonin sulphate excretion rates: Two non-invasive techniques for monitoring human circadian rhythmicity. Clin. Endocrinol. 27:445-452.
13. Panzer, A., M. Viljoen (1997) The validity of melatonin as an oncostatic agent. J. Pineal Res. 22:184 202.
14. Reiter, R.J., L. Tang, J.J. Garcia, A. Munoz-Hoyos (1997) Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci. 60:2255-2271.
15. Stevens, R.G. (1987) Electric power use and breast cancer: A hypothesis. Am. J. Epidemiol. 125:556-561.
16. Stevens, R.G., B.W. Wilson, L.E. Anderson (1997) Synthesis and conclusions. In: The Melatonin Hypothesis: Breast Cancer and Use of Electric Power, R.G. Stevens, B.W. Wilson, L.E. Anderson, eds. Battelle Press, Columbus, OH, pp. 739-747.
17. Tamarkin, I., D. Danforth, A. Lighter (1989) Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. Science 216:1003-1005.